RE:RE:$122,000 isn't a big chew
Jan 23, 2014 is when the hearing will be held. I wonder how long it will be before a decision is made.
In any event, I wonder if Novartis will make a play to buy out Microbix. Clearly they are interested in the technology and the possibilities it brings. Novartis may even not want to risk proceeding with the hearing and may make a play before hand, rather than risk losing the challenge.
Figure that a buy out at $50 - 100 million would put MBX stock at 0.75 - $1.50...something that both the acquirer and acquiree could live with. I know I'd be happy at that price. On the other hand, the huge earnings potential of this technology alone should bring greater fortunes as time goes on...so whether there is a buyout or not, the real issue hinges on the outcome of that hearing. Should be an interesting 2 weeks.